logo
Search orAI Icon𝛼SK
ENTITY
I-Mab

I-Mab (IMAB US)

63
Analysis
Health Care • China
I-Mab operates as a clinical stage biopharmaceutical company. The Company focuses on the discovery, development, and commercialization of novel biologics to treat diseases with significant unmet medical needs, particularly cancers and autoimmune disorders. I-Mab conducts business in China.
more
Company Event • 11 Dec 2025 20:00 • Upcoming
Add To Calendar

Q3 2025

Company Event • 17 Mar 2026 12:00 • Upcoming
Add To Calendar

Q4 2025

Company Event • 17 Oct 2025 04:45 • Latest

Investor Update

Company Event • 20 Aug 2025 19:00 • Upcoming
Add To Calendar

Q2 2025

Company Event • 09 Jul 2025 02:00

Status Update

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x